Use of diffusion weighted MRI to predict the occurrence and severity of hemorrhagic transformation in a rabbit model of embolic stroke

Brain Research

Volumn 944, Issue 1-2, 2002, Pages 32-39

  Adami, Alessandro ^b   Thijs, Vincent ^a   Tong, David C ^a   Beaulieu, Chris ^a,c   Moseley, Michael E ^a   Yenari, Midori A ^a  

^a STANFORD UNIVERSITY   (United States)

^b Ospedale S Cuore   (Italy)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Diffusion; Embolism; Hemorrhagic stroke; Magnetic resonance imaging; Rabbits

Indexed keywords

ALTEPLASE; HIRULOG; RETEPLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN TISSUE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; FIBRINOLYTIC THERAPY; HEMISPHERE; MALE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RABBIT; STROKE; THROMBOEMBOLISM;

ANIMALS; BLOOD PRESSURE; BRAIN; CAROTID ARTERY THROMBOSIS; CAROTID ARTERY, INTERNAL; CAUSALITY; CEREBRAL HEMORRHAGE; CEREBROVASCULAR ACCIDENT; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; INFARCTION, MIDDLE CEREBRAL ARTERY; MAGNETIC RESONANCE IMAGING; MALE; PREDICTIVE VALUE OF TESTS; RABBITS; RETROSPECTIVE STUDIES; SURVIVAL RATE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 0037135153     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)02704-X     Document Type: Article

References (31)

1. Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection
2. Predictors of hemorrhagic transformation occurring spontaneously and on anticoagulants in patients with acute ischemic stroke
3. Magnetic resonance imaging of acute stroke
4. Mechanism of detection of acute cerebral ischemia in rats by diffusion-weighted magnetic resonance microscopy
5. Morphological manifestation of reperfusion injury in brain
6. When is thrombolysis justified in patients with acute ischemic stroke? A bioethical perspective
7. Brain capillaries expand and rupture in areas of ischemia and reperfusion
8. Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion
9. Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion
10. Diffusion weighted NMR imaging: Application to experimental focal cerebral ischemia
11. Viability thresholds and the penumbra of focal ischemia
12. Prediction of impending hemorrhagic transformation in ischemic stroke using magnetic resonance imaging in rats
13. Diffusion-weighted MR imaging of acute cerebral ischemia
14. Hemorrhagic transformation after cerebral ischemia: Mechanisms and incidence
15. Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits
16. Magnetic resonance imaging of diffusion and perfusion
17. Magnetic resonance prediction of outcome after thrombolytic treatment
18. Cranial computed tomography interpretation in acute stroke: Physician accuracy in determining eligibility for thrombolytic therapy
19. Diffusion and perfusion magnetic resonance imaging for the evaluation of acute stroke: Potential use in guiding thrombolytic therapy
20. Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke
21. Relationship between apparent diffusion coefficient and subsequent hemorrhagic transformation following acute ischemic stroke
22. Prediction of hemorrhagic transformation following acute stroke: Role of diffusion- and perfusion-weighted magnetic resonance imaging
23. Outcome in acute stroke with successful intra-arterial thrombolysis and predictive value of initial single-photon emission-computed tomography
24. Complete separation of intracellular and extracellular information in NMR spectra of perfused cells by diffusion-weighted spectroscopy
25. Diffusion-weighted magnetic resonance imaging in acute stroke
26. Acute stroke: Usefulness of early CT findings before thrombolytic therapy
27. Thrombolysis with tissue plasminogen activator (tPA) is temperature dependent
28. Improved perfusion with rt-PA and hirulog in a rabbit model of embolic stroke
29. Thrombolysis with Reteplase, an unglycosylated plasminogen activator variant, in experimental embolic stroke
30. Prediction of hemorrhagic complications after thrombolytic therapy for middle cerebral artery occlusion: Value of pre- and post-therapeutic computed tomographic findings and angiographic occlusive site
31. Ischaemic damage of brain microvessels: Inherent risks for thrombolytic treatment in stroke